This provider's $3.7M in total Medicare payments ranks in the 74th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 5064% from 2022 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 5064% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2022 | $72.63 | $47.23 | 1.54x | $25.40 | $69.5K | 1.5K | 10 |
| 2023 | $81.44 | $63.73 | 1.28x | $17.71 | $3.6M | 56.3K | 64 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 5.5K | $1.3M | $241.99 | 1.28x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 14.1K | $484.7K | $34.40 | 1.28x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 2.4K | $457.9K | $194.77 | 1.28x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 6.4K | $387.6K | $60.90 | 1.28x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1.2K | $189.1K | $153.46 | 1.28x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 3.3K | $114.3K | $34.39 | 1.28x |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.2K | $110.4K | $50.28 | 1.28x |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 771 | $107.9K | $139.92 | 1.32x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.2K | $88.0K | $73.55 | 1.37x |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 1.2K | $40.5K | $34.42 | 1.30x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 1.2K | $29.3K | $24.52 | 1.28x |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 829 | $28.5K | $34.39 | 1.28x |
| 80053 | Blood test, comprehensive group of blood chemicals | 2.3K | $24.1K | $10.35 | 1.28x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 3.1K | $23.4K | $7.61 | 1.28x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 1.3K | $21.1K | $16.46 | 1.28x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 912 | $21.0K | $22.99 | 1.28x |
| 87581 | Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 528 | $18.2K | $34.45 | 1.34x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 161 | $18.1K | $112.14 | 1.28x |
| 87541 | Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique | 509 | $17.5K | $34.45 | 1.34x |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 1.3K | $17.0K | $13.12 | 1.28x |
This provider submits charges 1.28 times higher than what Medicare actually pays.
A markup ratio of 1.28x means for every $100 Medicare pays, this provider initially charges $128. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data